Conor McNamara
Stock Analyst at RBC Capital
(2.02)
# 2,935
Out of 4,749 analysts
104
Total ratings
41.56%
Success rate
-9.39%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Reiterates: Outperform | $299 → $277 | $222.74 | +24.36% | 8 | Jan 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Reiterates: Outperform | $481 | $357.65 | +34.49% | 10 | Jan 14, 2025 | |
| BIO Bio-Rad Laboratories | Reiterates: Outperform | $481 | $360.88 | +33.29% | 10 | Jan 14, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $17 → $13 | $4.93 | +163.69% | 6 | Nov 8, 2024 | |
| HOLX Hologic | Maintains: Sector Perform | $86 → $89 | $72.14 | +23.37% | 8 | Nov 5, 2024 | |
| ILMN Illumina | Maintains: Outperform | $252 → $254 | $132.74 | +91.35% | 12 | Nov 5, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $767 → $718 | $597.75 | +20.12% | 13 | Oct 24, 2024 | |
| RGEN Repligen | Reiterates: Outperform | $205 | $166.21 | +23.34% | 9 | Sep 26, 2024 | |
| AVTR Avantor | Reiterates: Outperform | $34 | $22.28 | +52.60% | 5 | Sep 26, 2024 | |
| QDEL QuidelOrtho | Reiterates: Outperform | $61 | $43.46 | +40.36% | 10 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $7 | $3.22 | +117.39% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $72 → $70 | $73.55 | -4.83% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.50 | +100.00% | 4 | Aug 7, 2024 |
Danaher
Jan 30, 2025
Reiterates: Outperform
Price Target: $299 → $277
Current: $222.74
Upside: +24.36%
Bio-Rad Laboratories
Jan 14, 2025
Reiterates: Outperform
Price Target: $481
Current: $357.65
Upside: +34.49%
Bio-Rad Laboratories
Jan 14, 2025
Reiterates: Outperform
Price Target: $481
Current: $360.88
Upside: +33.29%
Maravai LifeSciences Holdings
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $4.93
Upside: +163.69%
Hologic
Nov 5, 2024
Maintains: Sector Perform
Price Target: $86 → $89
Current: $72.14
Upside: +23.37%
Illumina
Nov 5, 2024
Maintains: Outperform
Price Target: $252 → $254
Current: $132.74
Upside: +91.35%
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $767 → $718
Current: $597.75
Upside: +20.12%
Repligen
Sep 26, 2024
Reiterates: Outperform
Price Target: $205
Current: $166.21
Upside: +23.34%
Avantor
Sep 26, 2024
Reiterates: Outperform
Price Target: $34
Current: $22.28
Upside: +52.60%
QuidelOrtho
Aug 16, 2024
Reiterates: Outperform
Price Target: $61
Current: $43.46
Upside: +40.36%
Aug 16, 2024
Reiterates: Outperform
Price Target: $7
Current: $3.22
Upside: +117.39%
Aug 8, 2024
Maintains: Sector Perform
Price Target: $72 → $70
Current: $73.55
Upside: -4.83%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.50
Upside: +100.00%